Dechra Pharmaceuticals (DPH) Pharma and Biotech Sector

  • Latest quote

    2,048.00p (mid)

  • Current Change (%)

    -1.30%

  • Price

    Bid: 2,048.00p

    Offer: 2,050.00p

  • Today

    High: 2,095.00p

    Low: 2,025.97p

  • This year

    High: 2,175.00p

    Low: 1,235.00p

  • Information

    Volume: 144,649

    Market Cap: £1906.5M


Dechra Pharmaceuticals RNS Feed

Title Release date
Result of AGM - 20 October 2017 14:35 - October 20, 2017
Pre Annual General Meeting Statement 07:00 - October 20, 2017
Holding(s) in Company 08:57 - October 18, 2017
Director/PDMR Shareholding 12:15 - October 12, 2017
Additional Listing 10:39 - October 12, 2017
Holding(s) in Company 09:39 - October 4, 2017
Total Voting Rights 12:49 - October 2, 2017
Director/PDMR Shareholding 16:25 - September 20, 2017
Director/PDMR Shareholding 11:30 - September 19, 2017
Annual Financial Report 09:07 - September 19, 2017
BLOCK LISTING SIX MONTHLY RETURN 14:00 - September 15, 2017
Additional Listing 10:02 - September 6, 2017
Availability of 2017 Annual Report and Accounts 10:09 - September 5, 2017
Director/PDMR Shareholding 12:55 - September 4, 2017
Preliminary Results Announcement -year end 30.6.17 07:00 - September 4, 2017

NOTE: This is based on 20 open tips for this company


Total Number of Share tips :

20

View all Dechra Pharmaceuticals Tips


Company overview

Dechra Pharmaceuticals, founded in 1997 following a management buy-out from Lloyds Chemists, develops prescription only veterinary medicines for dogs, cats and horses. Most of its projects involve adapting treatments, currently used by humans, for the animal market. Expertise is in the development, manufacturing and sales and marketing of high quality products exclusively for veterinarians worldwide. It listed in London in 2000.

Daily share tips delivered straight to your pc, tablet & mobile

Join Free Today